Autopsy report · NCT05345990

Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins

“A full recruitment for the study was no longer expected.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 3 years before it stopped.
• 13 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Hannover Medical School

Sponsor type

University, hospital or other

Conditions

Chronic Hepatitis B

Interventions

Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®)

Participants

13

Sites

1

Countries

Germany

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.